<?xml version="1.0" encoding="UTF-8"?>
<p>Retroviruses and lentiviruses are ssRNA, which can provide long-term transgene expression by integration into the host genome. They have frequently been used as gene therapy vectors for indications such as glioma [
 <xref rid="B77-biomedicines-08-00060" ref-type="bibr">77</xref>,
 <xref rid="B78-biomedicines-08-00060" ref-type="bibr">78</xref>], and breast [
 <xref rid="B81-biomedicines-08-00060" ref-type="bibr">81</xref>], gastric [
 <xref rid="B82-biomedicines-08-00060" ref-type="bibr">82</xref>], liver [
 <xref rid="B83-biomedicines-08-00060" ref-type="bibr">83</xref>], pancreatic [
 <xref rid="B84-biomedicines-08-00060" ref-type="bibr">84</xref>], and hematologic [
 <xref rid="B85-biomedicines-08-00060" ref-type="bibr">85</xref>] cancers. One limitation of using retroviruses such as Moloney murine leukemia virus (MoMLV) for gene therapy is the requirement of cell division for transduction and integration [
 <xref rid="B125-biomedicines-08-00060" ref-type="bibr">125</xref>]. In contrast, lentiviruses are capable of transduction of both dividing and non-dividing cells.
</p>
